Literature DB >> 27230643

Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes.

Manasi S Shah1, Michael Brownlee2.   

Abstract

The clinical correlations linking diabetes mellitus with accelerated atherosclerosis, cardiomyopathy, and increased post-myocardial infarction fatality rates are increasingly understood in mechanistic terms. The multiple mechanisms discussed in this review seem to share a common element: prolonged increases in reactive oxygen species (ROS) production in diabetic cardiovascular cells. Intracellular hyperglycemia causes excessive ROS production. This activates nuclear poly(ADP-ribose) polymerase, which inhibits GAPDH, shunting early glycolytic intermediates into pathogenic signaling pathways. ROS and poly(ADP-ribose) polymerase also reduce sirtuin, PGC-1α, and AMP-activated protein kinase activity. These changes cause decreased mitochondrial biogenesis, increased ROS production, and disturbed circadian clock synchronization of glucose and lipid metabolism. Excessive ROS production also facilitates nuclear transport of proatherogenic transcription factors, increases transcription of the neutrophil enzyme initiating NETosis, peptidylarginine deiminase 4, and activates the NOD-like receptor family, pyrin domain-containing 3 inflammasome. Insulin resistance causes excessive cardiomyocyte ROS production by increasing fatty acid flux and oxidation. This stimulates overexpression of the nuclear receptor PPARα and nuclear translocation of forkhead box O 1, which cause cardiomyopathy. ROS also shift the balance between mitochondrial fusion and fission in favor of increased fission, reducing the metabolic capacity and efficiency of the mitochondrial electron transport chain and ATP synthesis. Mitochondrial oxidative stress also plays a central role in angiotensin II-induced gap junction remodeling and arrhythmogenesis. ROS contribute to sudden death in diabetics after myocardial infarction by increasing post-translational protein modifications, which cause increased ryanodine receptor phosphorylation and downregulation of sarco-endoplasmic reticulum Ca(++)-ATPase transcription. Increased ROS also depress autonomic ganglion synaptic transmission by oxidizing the nAch receptor α3 subunit, potentially contributing to the increased risk of fatal cardiac arrhythmias associated with diabetic cardiac autonomic neuropathy.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  atherosclerosis; diabetes mellitus; heart failure; insulin resistance; myocardial infarction; reactive oxygen species

Mesh:

Year:  2016        PMID: 27230643      PMCID: PMC4888901          DOI: 10.1161/CIRCRESAHA.116.306923

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  176 in total

Review 1.  Critical nodes in signalling pathways: insights into insulin action.

Authors:  Cullen M Taniguchi; Brice Emanuelli; C Ronald Kahn
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

2.  Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes.

Authors:  Rita M Maalouf; Assaad A Eid; Yves C Gorin; Karen Block; Gladys Patricia Escobar; Steven Bailey; Hanna E Abboud
Journal:  Am J Physiol Cell Physiol       Date:  2011-10-26       Impact factor: 4.249

3.  Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity.

Authors:  Lale Ozcan; Catherine C L Wong; Gang Li; Tao Xu; Utpal Pajvani; Sung Kyu Robin Park; Anetta Wronska; Bi-Xing Chen; Andrew R Marks; Akiyoshi Fukamizu; Johannes Backs; Harold A Singer; John R Yates; Domenico Accili; Ira Tabas
Journal:  Cell Metab       Date:  2012-04-12       Impact factor: 27.287

4.  Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry.

Authors:  Paul J Thornalley; Sinan Battah; Naila Ahmed; Nikolaos Karachalias; Stamatina Agalou; Roya Babaei-Jadidi; Anne Dawnay
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

5.  Increased superoxide and endothelial NO synthase uncoupling in blood vessels of Bmal1-knockout mice.

Authors:  Ciprian B Anea; Bo Cheng; Shruti Sharma; Sanjiv Kumar; R William Caldwell; Lin Yao; M Irfan Ali; Ana M Merloiu; David W Stepp; Stephen M Black; David J R Fulton; R Daniel Rudic
Journal:  Circ Res       Date:  2012-08-20       Impact factor: 17.367

6.  Identification of a physiologically relevant endogenous ligand for PPARalpha in liver.

Authors:  Manu V Chakravarthy; Irfan J Lodhi; Li Yin; Raghu R V Malapaka; H Eric Xu; John Turk; Clay F Semenkovich
Journal:  Cell       Date:  2009-07-30       Impact factor: 41.582

7.  Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression.

Authors:  Mark J Crabtree; Amy L Tatham; Yasir Al-Wakeel; Nicholas Warrick; Ashley B Hale; Shijie Cai; Keith M Channon; Nicholas J Alp
Journal:  J Biol Chem       Date:  2008-11-14       Impact factor: 5.157

8.  Mitochondrial reactive oxygen species in the pathogenesis of early diabetic nephropathy.

Authors:  Takeshi Nishikawa; Michael Brownlee; Eiichi Araki
Journal:  J Diabetes Investig       Date:  2014-07-25       Impact factor: 4.232

9.  MicroRNAs in diabetic cardiomyopathy and clinical perspectives.

Authors:  Qiulian Zhou; Dongchao Lv; Ping Chen; Tianzhao Xu; Siyi Fu; Jin Li; Yihua Bei
Journal:  Front Genet       Date:  2014-06-25       Impact factor: 4.599

Review 10.  NLRP3 inflammasome and its inhibitors: a review.

Authors:  Bo-Zong Shao; Zhe-Qi Xu; Bin-Ze Han; Ding-Feng Su; Chong Liu
Journal:  Front Pharmacol       Date:  2015-11-05       Impact factor: 5.810

View more
  150 in total

Review 1.  Metabolic Regulation of Angiogenesis in Diabetes and Aging.

Authors:  Naoki Sawada; Zolt Arany
Journal:  Physiology (Bethesda)       Date:  2017-07

Review 2.  Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

3.  Endothelial TNF-α induction by Hsp60 secreted from THP-1 monocytes exposed to hyperglycaemic conditions.

Authors:  Ryan Dennis Martinus; Julie Goldsbury
Journal:  Cell Stress Chaperones       Date:  2017-11-13       Impact factor: 3.667

4.  Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes.

Authors:  Jenny E Kanter; Baohai Shao; Farah Kramer; Shelley Barnhart; Masami Shimizu-Albergine; Tomas Vaisar; Mark J Graham; Rosanne M Crooke; Clarence R Manuel; Rebecca A Haeusler; Daniel Mar; Karol Bomsztyk; John E Hokanson; Gregory L Kinney; Janet K Snell-Bergeon; Jay W Heinecke; Karin E Bornfeldt
Journal:  J Clin Invest       Date:  2019-07-11       Impact factor: 14.808

Review 5.  Immune aging in diabetes and its implications in wound healing.

Authors:  J Moura; P Madureira; E C Leal; A C Fonseca; E Carvalho
Journal:  Clin Immunol       Date:  2019-02-05       Impact factor: 3.969

6.  Topical L-thyroxine: The Cinderella among hormones waiting to dance on the floor of dermatological therapy?

Authors:  Ralf Paus; Yuval Ramot; Robert S Kirsner; Marjana Tomic-Canic
Journal:  Exp Dermatol       Date:  2020-08-28       Impact factor: 3.960

7.  SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.

Authors:  Xiaoqiang Tang; Xiao-Feng Chen; Nan-Yu Wang; Xiao-Man Wang; Shu-Ting Liang; Wei Zheng; Yun-Biao Lu; Xiang Zhao; De-Long Hao; Zhu-Qin Zhang; Ming-Hui Zou; De-Pei Liu; Hou-Zao Chen
Journal:  Circulation       Date:  2017-09-25       Impact factor: 29.690

Review 8.  Challenges in vascular tissue engineering for diabetic patients.

Authors:  Jhilmil Dhulekar; Agneta Simionescu
Journal:  Acta Biomater       Date:  2018-02-01       Impact factor: 8.947

Review 9.  Linking diabetic vascular complications with LncRNAs.

Authors:  Amy Leung; Vishnu Amaram; Rama Natarajan
Journal:  Vascul Pharmacol       Date:  2018-02-03       Impact factor: 5.773

10.  Binding to heparin triggers deleterious structural and biochemical changes in human low-density lipoprotein, which are amplified in hyperglycemia.

Authors:  Shobini Jayaraman; Olivia R Chavez; Antonio Pérez; Inka Miñambres; Jose Luis Sánchez-Quesada; Olga Gursky
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-04-11       Impact factor: 4.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.